PCSK9调控LOX-1介导的ox-LDL摄取及机制
该研究在THP-1源性巨噬细胞中观察PCSK9对LOX-1介导ox-LDL摄取的影响及信号机制。结果显示PCSK9可上调LOX-1表达并增加ox-LDL摄取和脂质蓄积,该效应可能通过TLR4/NF-κB/COX-2/ROS通路实现。
要点
- PCSK9上调巨噬细胞LOX-1表达并增加ox-LDL摄取。
- PCSK9促脂质蓄积可被抗LOX-1抗体减弱。
- TLR4/NF-κB/COX-2/ROS通路参与PCSK9上调LOX-1。
核心结论
- PCSK9可能通过THP-1源性巨噬细胞TLR4/NF-κB/COX-2/ROS途径调节LOX-1介导的ox-LDL摄取。
研究设计与样本
- THP-1单核细胞经PMA孵育48小时诱导分化为巨噬细胞。
- 人重组PCSK9蛋白预处理巨噬细胞1小时后与ox-LDL孵育24小时诱导泡沫细胞。
- 采用油红O染色、酶法、real-time PCR和Western blot检测脂质蓄积及LOX-1表达。
- 用荧光显微镜观察Dil-ox-LDL摄取,并检测TLR4、NF-κB、COX-2表达及ROS生成。
主要发现
- PCSK9组细胞内脂滴综合光密度、总胆固醇、胆固醇酯及胆固醇酯/总胆固醇比值均高于对照组(P均<0.05)。
- PCSK9组LOX-1 mRNA和蛋白表达均高于对照组(P均<0.05)。
- PCSK9+抗LOX-1抗体组Dil-ox-LDL荧光强度低于PCSK9组与PCSK9+IgG抗体组(P均<0.05)。
- PCSK9组TLR4、NF-κB、COX-2 mRNA和蛋白表达均高于相应对照组(P均<0.05)。
- PCSK9+NS-398和PCSK9+DPI组ROS水平均低于PCSK9组(P均<0.05);TAK-242、PDTC、NS-398、DPI分别与PCSK9共孵育组LOX-1 mRNA和蛋白表达均低于PCSK9单独孵育组(P均<0.05)。
关键数值与推荐
- PCSK9组与对照组比较:细胞内脂滴综合光密度、总胆固醇、胆固醇酯、胆固醇酯/总胆固醇比值及LOX-1表达均升高,P均<0.05。
- PCSK9+抗LOX-1抗体组Dil-ox-LDL荧光强度低于PCSK9组和PCSK9+IgG抗体组,P均<0.05。
- PCSK9组TLR4、NF-κB、COX-2表达高于相应对照组,P均<0.05。
- PCSK9+NS-398和PCSK9+DPI组ROS水平低于PCSK9组,P均<0.05。
- TAK-242、PDTC、NS-398、DPI分别与PCSK9共孵育组LOX-1 mRNA和蛋白表达均低于PCSK9单独孵育组,P均<0.05。
临床怎么用
- 提示PCSK9除调节LDL受体外,还可能通过LOX-1通路影响巨噬细胞脂质摄取。
- 为PCSK9抑制剂在动脉粥样硬化中的作用机制提供细胞水平线索。
局限性
- 研究为THP-1源性巨噬细胞体外实验,结论需体内研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effect and mechanism of proprotein convertase subtilisin type 9 (PCSK9) on lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) mediated oxidized low-density lipoprotein (ox-LDL) uptake by mononuclear macrophage (THP-1) derived macrophages. Methods: THP-1 monocyte was incubated with PMA for 48 hours to induce the differentiation into macrophages. Macrophages were pretreated with human recombinant PCSK9 protein for 1 hour and incubated with ox-LDL for 24 hours to induce foam cells. Oil red O staining was used to observe the accumulation of lipid in the control group (foam cells) and groups treated with different concentrations of recombinant PCSK9 protein, and the intracellular cholesterol content was measured by enzyme method, and mRNA and protein expressions of LOX-1 were detected by real-time PCR and Western blot. The uptake of Dil-labeled oxidized low density lipoprotein (Dil-ox-LDL) was observed by fluorescence microscopy in control group (macrophage), PCSK9 protein treated group and PCSK9 protein plus anti-LOX-1 antibody and IgG antibody treated group. mRNA and protein expression of toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-κB), cyclooxygenase-2 (COX-2) were detected in control and PCSK9 protein treated group in the absence and presence of TLR4 inhibitor (TAK-242), NF-κB inhibitor (PDTC). In addition, reactive oxygen species (ROS) production was evaluated in the absence or presence of COX-2 inhibitor (NS-398) or reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor (DPI). The mRNA and protein expression of LOX-1 in the control group (PCSK9 protein pretreated foam cells) and PCSK9 protein group in the absence or presence of TAK-242, PDTC, NS-398 and DPI respectively. Results: (1) The total optical density of intracellular lipid droplets, total cholesterol level, cholesterol ester level and cholesterol ester/total cholesterol ratio as well as expression of LOX-1 were significantly higher in PCSK9 group than those in control group (all P<0.05). (2) The fluorescence intensity of Dil-ox-LDL was significantly higher in PCSK9 group and PCSK9+IgG antibody group than in the control group (all P<0.05). The fluorescence intensity was significantly lower in PCSK9+anti-LOX-1 antibody group than in PCSK9 group and PCSK9+IgG antibody group (all P<0.05). (3) The expressions of TLR4, NF-κB and COX-2 were significantly higher in PCSK9 group than in control group (all P<0.05). The expressions of TLR4, NF-κB and COX-2 were significantly lower in PCSK9+TAK-242 group and PCSK9+PDTC group than in PCSK9 group (all P<0.05). The ROS level was significantly higher in PCSK9 group than in the control group (P<0.05). The ROS levels were significantly lower in PCSK9+NS-398 and PCSK9+DPI groups than in PCSK9 group (all P<0.05). (4) The expressions of LOX-1 mRNA and protein were lower in respective PCSK9 protein plus TAK-242, PDTC, NS-398 or DPI group than in PCSK9 protein alone (all P<0.05). Conclusion: PCSK9 may regulate LOX-1 mediated ox-LDL uptake by the THP-1 derived macrophage via TLR4/NF-κB/COX-2/ROS pathway. 目的: 探讨前蛋白转化酶枯草溶菌素9(PCSK9)对单核巨噬细胞THP-1源性巨噬细胞血凝素样氧化低密度脂蛋白受体-1(LOX-1)介导的氧化低密度脂蛋白(ox-LDL)摄取的影响及机制。 方法: 用丙二醇甲醚醋酸酯孵育THP-1单核细胞48 h诱导分化成巨噬细胞,人重组PCSK9蛋白预处理巨噬细胞1 h后,与ox-LDL孵育24 h诱导为泡沫细胞,油红O染色观察对照组(泡沫细胞)与不同浓度人重组PCSK9蛋白孵育组细胞内脂质蓄积情况,酶法测定细胞内胆固醇含量,实时荧光定量聚合酶链反应(real-time PCR)与Western blot法检测LOX-1 mRNA和蛋白表达。荧光显微镜观察对照组(巨噬细胞)、PCSK9蛋白单独孵育组和PCSK9蛋白与抗LOX-1抗体、IgG抗体共孵育组对Dil标记氧化低密度脂蛋白(Dil-ox-LDL)的摄取情况。检测对照组(泡沫细胞)与PCSK9蛋白组对Toll样受体4(TLR4)、核因子κB(NF-κB)、环氧合酶-2(COX-2)mRNA和蛋白表达影响,以及PCSK9蛋白与TLR4抑制剂(TAK-242)共同孵育组NF-κB mRNA和蛋白表达影响,与NF-κB抑制剂(PDTC)共同孵育组COX-2 mRNA和蛋白表达影响,与COX-2抑制剂(NS-398)或还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶抑制剂(DPI)共同孵育组活性氧簇(ROS)生成的影响。检测对照组(PCSK9蛋白预处理泡沫细胞)和PCSK9蛋白分别与TAK-242、PDTC、NS-398、DPI共同孵育组LOX-1 mRNA和蛋白表达。 结果: (1)PCSK9组细胞内脂滴综合光密度、总胆固醇、胆固醇酯和胆固醇酯/总胆固醇比值均高于对照组(P均<0.05),PCSK9组LOX-1 mRNA和蛋白表达均高于对照组(P均<0.05)。(2)PCSK9组与PCSK9+IgG抗体组巨噬细胞Dil-ox-LDL荧光强度高于对照组(P均<0.05),PCSK9+抗LOX-1抗体组荧光强度低于PCSK9组与PCSK9+IgG抗体组(P均<0.05)。(3)PCSK9组TLR4、NF-κB、COX-2 mRNA和蛋白表达均高于相应对照组(P均<0.05),PCSK9+TAK-242组TLR4、NF-κB与PCSK9+PDTC组NF-κB、COX-2 mRNA和蛋白表达均低于相应PCSK9组(P均<0.05)。PCSK9组ROS水平高于对照组(P<0.05),PCSK9+NS-398和PCSK9+DPI组ROS水平均低于PCSK9组(P均<0.05)。(4)TAK-242、PDTC、NS-398、DPI分别与PCSK9蛋白共孵育组的LOX-1 mRNA和蛋白表达均低于PCSK9蛋白单独孵育组(P均<0.05)。 结论: PCSK9可能通过THP-1源性巨噬细胞TLR4/NF-κB/COX-2/ROS途径调节LOX-1介导的ox-LDL摄取。.
引用
- Bao HL, Liao FJ, Fang L, et al. [Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 31142080. doi:10.3760/cma.j.issn.0253-3758.2019.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。